Olema Pharmaceuticals Inc.

OLMA | NASDAQ

Price Alert Chart Builder DCF Calculator

$9.64

-$0.18 (-1.83%)

At close: Sep 21, 2026, 4:00 PM ET

$9.81

+$0.17 (+1.76%)

Pre-market: Sep 22, 2026, 5:49 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-162.45M	-129.47M	-96.66M	-104.79M	-71.1M	-22.12M
Depreciation & Amortization	490K	393K	377K	1.66M	1.66M	11K
Stock-Based Compensation	17.59M	22.58M	17.26M	n/a	n/a	3.11M
Other Working Capital	-1.82M	6.65M	-2.91M	2.67M	3.51M	-1.29M
Other Non-Cash Items	-5.12M	-7.02M	-4.12M	18.04M	15.91M	641K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	2.78M	9.16M	-589K	3.02M	2.83M	-1.51M
Operating Cash Flow	-146.72M	-104.35M	-83.73M	-82.07M	-50.69M	-19.87M
Capital Expenditures	n/a	-159K	n/a	-363K	-1.58M	-56K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-500.72M	-394.96M	-255.63M	-213.66M	-486.97M	n/a
Sales Maturities Of Investments	344.96M	301.59M	250.76M	305.5M	213.1M	n/a
Other Investing Acitivies	n/a	n/a	14K	n/a	n/a	n/a
Investing Cash Flow	-155.76M	-93.53M	-4.85M	91.48M	-275.44M	-56K
Debt Repayment	3M	n/a	n/a	n/a	n/a	3.09M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	-2.29M
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	2.53M	3.68M	n/a	n/a	n/a
Financial Cash Flow	211.3M	268.82M	133.42M	476K	1.39M	358.4M
Net Cash Flow	-91.18M	70.94M	44.84M	9.89M	-324.74M	338.48M
Free Cash Flow	-146.72M	-104.51M	-83.73M	-82.43M	-52.27M	-19.92M
Adj. Free Cash Flow	-164.3M	-127.09M	-100.98M	-82.43M	-52.27M	-23.03M
Maintenance CapEx	n/a	-159K	n/a	-363K	-1.58M	-11K
Growth CapEx	n/a	n/a	n/a	n/a	n/a	-45K
Owner Earnings	-146.72M	-104.51M	-83.73M	-82.43M	-52.27M	-19.88M